Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Reviva and FDA Reach Consensus on Brilaroxazine Clinical Trials for Schizophrenia NDA

Tuesday, April 16, 2024

Reviva Pharmaceuticals Holdings Inc a prominent latestage pharmaceutical company specializing in addressing unmet medical needs in central nervous system inflammatory

Expansion Study for Bile Tract Cancer Commences Following Approval of Imugene’s MAST Trial High Dose Cohort

Tuesday, April 16, 2024

Imugene Limited has initiated enrollment for its expansion study targeting bile tract cancer patients This comes after completing the fifth cohort in the high dose segment of the intratumoural

BC Platforms and NTT Group Announce Inaugural Ceremony for Exclusive Collaboration and Debut of Japanese Precision Medicine Platform

Monday, April 15, 2024

BC Platforms and NTT Life Science Corporation have teamed up in an exclusive partnership to advance datadriven medicine particularly in Japan The collaboration

Teva Confirms AJOVY® (fremanezumab) Effectiveness and Safety in Preventing Migraines with Phase 3 Trial Results in China

Friday, April 12, 2024

Teva Pharmaceuticals a subsidiary of Teva Pharmaceutical Industries Ltd has released findings from a Phase trial examining the effectiveness and safety of AJOVY in preventing migraines in adult Chinese

Sen-Jam Pharma Collaborates with Specialty Manufacturer for Innovative Anti-Inflammatory Injectable

Thursday, April 11, 2024

SenJam Pharmaceutical an innovative player in the life sciences field is embarking on its third strategic collaboration this time with KVKTech a leading Specialty Pharmaceutical Manufacturing company

Phanes Therapeutics' PT217 Receives Fast Track Designation from FDA

Wednesday, April 10, 2024

Phanes Therapeutics Inc a biotechnology company specializing in innovative oncology drug discovery and development announced today that the US Food and Drug Administration has granted Fast Track designation to PT for the treatment of patients with ex...

MAIWEIJIAN Becomes China's Initial Approved Biosimilar for Denosumab (120mg)

Wednesday, April 10, 2024

Mabwell an innovative biopharmaceutical company with a complete industry chain has announced that its whollyowned subsidiary Tmab has received marketing authorization approval from the National Medical

Mitsubishi Tanabe Pharma America Granted Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) by FDA

Tuesday, April 09, 2024

Mitsubishi Tanabe Pharma America Inc has announced that the US Food and Drug Administration has granted seven years of Orphan Drug Exclusivity for RADICAVA ORS This recognition is based on the FDAs

Junshi Biosciences Obtains Approval for sNDA of Toripalimab for First-Line Renal Cancer Treatment

Monday, April 08, 2024

Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company dedicated to innovating therapies has announced the approval of a supplemental new drug application sNDA for toripalimab

Recent Analyses from REDUCE-IT® Demonstrate Benefits of Vascepa®/Vazkepa® (Icosapent Ethyl) in Specific High-Risk Cardiovascular Disease Patient Groups

Saturday, April 06, 2024

Amarin Corporation plc unveiled two data presentations at ACC spotlighting the effects